Premium
Effect of Green Tea Catechins on the Growth of MDA‐MB 468 Breast Cancer Cells
Author(s) -
Mahadeo Arianna,
RamirezMedrano Leslie,
DelgadoCruzata Lissette
Publication year - 2021
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2021.35.s1.02614
Subject(s) - breast cancer , cell growth , cancer cell , green tea , cancer , growth inhibition , polyphenol , catechin , mtt assay , mcf 7 , chemistry , significant difference , medicine , endocrinology , cancer research , human breast , biochemistry , food science , antioxidant
Breast cancer is the most commonly diagnosed cancer in women. Diet is considered an important factor in breast cancer prevention and studies suggest that green tea consumption has the potential to reduce breast cancer risk. Catechins, a group of polyphenols that are found in plants, have been shown to have anti‐tumor effects . Many studies have investigated EGCG, but less is known about epicatechin. We investigated the inhibition of cell proliferation in the breast cancer cell lines, MDA‐MB 468 after exposure to varying concentrations of EGCG and epicatechin. Changes in proliferation were determined using the MTT assay after exposing cells for 24 and 48 hours to concentrations of catechins ranging from 1μM to 500μM. We found that after 24‐hr exposure, the cells significantly decreased in growth with a lower percent of cells remaining after exposure to 500μM EGCG. Percentage of cells was higher at 1μM when compared to 500μM . However, when the cells were exposed to epicatechin in that same time period, there was no significant difference. We found that as time increased from 24 to 48 hours, EGCG significantly inhibited the growth of cancer cells at 500μM . No effect was observed for epicatechin in growth as time increased. At an exposure of 500μM epicatechin, a higher percentage of cells were alive at 24 hours when compared to 48 hours but average values among experiments were not statistically significant. Our findings suggest that EGCG is a more potent inhibitor of triple negative breast cancer cell growth than epicatechin.